125,000,000 Principal Amount (Includes Exercise of Over-allotment Option In Full) 4 1/4% CONVERTIBLE SUBORDINATED NOTES DUE 2008 CROSS-REFERENCE TABLE*Indenture • April 2nd, 2003 • Axcan Pharma Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
Contract Type FiledApril 2nd, 2003 Company Industry Jurisdiction
DEBT SECURITIES (TITLE OF THE INDENTURE SECURITIES)Trust Indenture Act Eligibility Statement • April 2nd, 2003 • Axcan Pharma Inc • Wholesale-drugs, proprietaries & druggists' sundries
Contract Type FiledApril 2nd, 2003 Company Industry